G protein–coupled receptors (GPCRs) play a central role in numerous physiological processes and represent a major class of drug targets. However, their structural flexibility and complex signaling networks present significant challenges in drug discovery. Factors such as receptor heterogeneity, pleiotropic signaling pathways, ligand-dependent bias, and cellular context can influence assay performance and contribute to variability in data interpretation.
In this webinar, we will explore the major classes of GPCRs, their diverse signaling mechanisms, and the implications of these factors for assay development. We will also highlight GPCRs as therapeutic targets across diverse indications.
Additionally, we will address the challenges associated with GPCR deorphanization and its impact on assay design and screening strategies.
This session will emphasize how a deep understanding of GPCR biology will be critical for the development of robust and predictive screening assays. Key topics will include selecting appropriate assay formats, developing suitable tools and reagents, and balancing throughput requirements during screening. We will also review common pitfalls in GPCR screening and outline strategies to mitigate these issues through assay optimization.
By integrating biological insight with technical expertise, this webinar will provide a practical roadmap for designing effective screening workflows for GPCR-targeted drug discovery.
Register now to secure your place and gain actionable insights.
Key takeaways:
